Affordable Access

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors
  • Heijl, Anders
  • Leske, M Cristina
  • Bengtsson, Bo
  • Hyman, Leslie
  • Bengtsson, Boel
  • Hussein, Mohamed
Type
Published Article
Journal
Archives of Ophthalmology
Publisher
American Medical Association
Publication Date
Oct 01, 2002
Volume
120
Issue
10
Pages
1268–1279
Identifiers
PMID: 12365904
Source
Medline
License
Unknown

Abstract

The Early Manifest Glaucoma Trial is the first adequately powered randomized trial with an untreated control arm to evaluate the effects of IOP reduction in patients with open-angle glaucoma who have elevated and normal IOP. Its intent-to-treat analysis showed considerable beneficial effects of treatment that significantly delayed progression. Whereas progression varied across patient categories, treatment effects were present in both older and younger patients, high- and normal-tension glaucoma, and eyes with less and greater visual field loss.

Report this publication

Statistics

Seen <100 times